The Hepatitis C Virus Antibody (HCV Ab) test is a blood test that checks for antibodies your immune system makes after being exposed to the hepatitis C virus (HCV)—often called hep C. Antibodies are “memory” proteins that show your body has encountered the virus at some point.

This is primarily a screening test. It does not measure the virus itself. A positive (reactive) HCV antibody result usually means one of the following:

• Past infection that has cleared (some people clear HCV on their own), or
• Current hepatitis C infection (the most common reason for a positive antibody test), or
• Rarely, a false-positive result (more likely in low-risk settings).

A negative (non-reactive) result usually means you have not been exposed to HCV. However, if exposure was recent, antibodies may not be detectable yet (a “window period”). In that situation, your clinician may repeat testing or order an HCV RNA test.

If the HCV Ab test is positive, the next step is typically a confirmatory blood test called HCV RNA (PCR), which checks whether the virus is currently in your bloodstream. This follow-up test helps determine whether you have an active hepatitis C infection and need treatment.

Clinicians order an HCV antibody test to screen for hepatitis C exposure, especially because many people with hep C have no symptoms for years. Early detection matters because effective treatments can cure most cases and help prevent long-term liver damage.

This test is commonly done for:

Screening

• As part of routine adult screening (many guidelines recommend at least one-time screening for adults, and ongoing screening for higher-risk individuals).
• During pregnancy in many care settings, to identify infection early and plan follow-up care.

Symptoms or signs that may suggest hepatitis C or liver inflammation

• Fatigue, nausea, loss of appetite
• Abdominal discomfort (especially right upper abdomen)
• Dark urine or pale stools
• Yellowing of skin/eyes (jaundice)
• Itching, unexplained joint aches
• Elevated liver enzymes (ALT/AST) on other blood tests

Risk factors or possible exposures to HCV

• Current or past injection drug use (even once), or sharing needles/syringes or other drug equipment
• Needlestick injury or occupational exposure to blood (healthcare, first responders)
• Receiving blood transfusions or organ transplants before widespread screening of the blood supply (in the U.S., especially before 1992)
• Long-term hemodialysis
• Tattoos or piercings done with non-sterile equipment
• Sharing personal items that may have blood (razors, toothbrushes, nail tools)
• HIV infection or other conditions that increase risk of blood-borne infections
• Being born to a mother with hepatitis C
• Sexual exposure risk (risk is generally lower than with some other infections but increases with certain factors, including HIV or traumatic sexual practices)

If you’ve had a recent possible exposure and the antibody test is negative, your clinician may recommend repeat testing and/or an HCV RNA test to check for early infection.

• Acute hepatitis C infection
• Chronic hepatitis C (chronic HCV infection)
• Chronic liver disease due to hepatitis C
• Liver fibrosis and cirrhosis
• Hepatocellular carcinoma (liver cancer) related to chronic HCV
• Mixed cryoglobulinemia (an HCV-associated immune condition)
• Glomerulonephritis (kidney inflammation associated with HCV)

• Hepatitis C (hep C) screening and early detection
• Protecting long-term liver health by identifying infection before cirrhosis develops
• Clarifying the cause of elevated liver enzymes (ALT/AST) as part of liver function evaluation
• Preventing transmission to others through timely diagnosis and treatment planning
• Guiding follow-up testing (HCV RNA) to confirm active infection and support cure-focused treatment decisions
• General preventive health screening for blood-borne infections in higher-risk situations